Nasacort and Levothroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort (triamcinolone acetonide) and Levothroid (levothyroxine sodium). Common drug interactions include abdominal pain upper among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Nasacort and Levothroid. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.



On Aug, 01, 2026

19 people who take Nasacort and Levothroid together, and have interactions are studied.

Nasacort and Levothroid drug interactions.

What are the common drug interactions of Nasacort and Levothroid, by gender? *:

female:

  1. Abdominal pain upper
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Alanine aminotransferase increased
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Ankle fracture
  6. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  7. Anticonvulsant drug level decreased
  8. Anxiety
  9. Arrhythmia (irregular heartbeat)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Anxiety
  3. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  4. Hypotension (abnormally low blood pressure)
  5. Muscle spasms (muscle contraction)
  6. Tardive dyskinesia (a disorder that involves involuntary movements)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Abdominal adhesions (inflammation of abdomen)
  9. Abscess limb (limb infection)
  10. Acute sinusitis

What are the common drug interactions of Nasacort and Levothroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Muscle spasms (muscle contraction)
  3. Oedema peripheral (superficial swelling)
  4. Pain in extremity

40-49:

  1. Petechiae (a small red or purple spot caused by bleeding into the skin)
  2. Anticonvulsant drug level decreased
  3. Diarrhoea
  4. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

50-59:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  3. Hypotension (abnormally low blood pressure)
  4. Nausea (feeling of having an urge to vomit)
  5. Culture urine positive

60+:

  1. Asthenia (weakness)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Alanine aminotransferase increased
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Ankle fracture
  6. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  7. Anxiety
  8. Aphonia (inability to produce voice)
  9. Arrhythmia (irregular heartbeat)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

What are the existing conditions these people have? *

  1. Pain: 5 people, 26.32%
  2. Impaired Gastric Emptying: 4 people, 21.05%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 21.05%
  4. Hypersensitivity: 4 people, 21.05%
  5. Rashes (redness): 3 people, 15.79%
  6. High Blood Pressure: 3 people, 15.79%
  7. Vertigo Positional: 2 people, 10.53%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 10.53%
  9. Cough: 2 people, 10.53%
  10. Depression: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and Levothroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasacort and Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasacort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and levothyroxine sodium (the active ingredients of Nasacort and Levothroid, respectively), and Nasacort and Levothroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: